Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Nitin Narain, a survivor of Guillain-Barre Syndrome (GBS), recounts his harrowing experience with the disease and his long ...
A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré ...
Seventeen patients diagnosed with Guillain-Barré Syndrome (GBS) are currently receiving treatment at Government General ...
State government is yet to form a cohesive plan to treat patients, procure life-saving immunotherapy drugs and take up and ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Global Business Summit 2025, set for February 15-16 in New Delhi, will feature visionary innovators shaping the future of ...
The Food and Drug Administration (FDA) Maharashtra State had directed the Pune Municipal Corporation (PMC) for the testing of ...
The lack of data evaluating the clinical manifestations of adverse drug reactions before and during pregnancy shows need for more research in this area for this patient population, according to Ruchi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback